Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $128.58, giving the company a market capitalization of 319.04B. It carries a P/E multiple of 35.96 and pays a dividend yield of 2.63%.
During the trading session on 2026-08-08, Merck(MRK) shares reached a daily high of $128.88 and a low of $126.68. At a current price of $128.58, the stock is +1.5% higher than the low and still -0.2% under the high.
Trading activity shows a volume of 7.35M, compared to an average daily volume of 8.82M.
The stock's 52-week range extends from a low of $77.58 to a high of $135.05.
The stock's 52-week range extends from a low of $77.58 to a high of $135.05.
MRK News
Insiders have been trading these 5 stocks: ((COIN)), ((GM)), ((DAL)), ((MRK)) and ((APLD)). Here is a breakdown of their recent trades and their value. Directo...
New insider activity at Merck & Company ( (MRK) ) has taken place on August 7, 2026. Recent insider activity at Merck & Company shows three senior executives c...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...
Analyst ratings
63%
of 30 ratingsMore MRK News
...
In recent days, Merck reported Q2 2026 results with sales rising to US$16.61 billion and updated 2026 revenue guidance to US$66.3–US$67.3 billion, while also an...
Merck (MRK) announced that the U.S. FDA has accepted a supplemental Biologics License Application for enflonsia to expand its indication to include prevention o...
Merck (MRK) on Thursday announced that the FDA has accepted its marketing application aimed at expanding the U.S. label of Enflonsia, an antibody therapy design...
Merck (MRK) announced that KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with enfortumab vedotin, an antibody-drug conjugate, is approved by Health Canada...
The race to treat obesity and metabolic disease is reshaping expectations across large pharmaceutical stocks, and Eli Lilly is front and center after its Q2 ear...
Merck Revenue Tops Estimates Despite Acquisition Charges The company reported an adjusted loss of 13 cents per share, narrower than analysts’ expected loss of...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.